Standing ballistocardiography measurements in microgravity

The performance and practicality of a scale-based ballistocardiogram (BCG) system for hemodynamic monitoring of astronauts on extended space missions was demonstrated. The system consists of a modified electronic weighing scale fitted with foot bindings to mechanically couple the subject to the scale. This system was tested on a recent series of parabolic flights in which scale-based and accelerometry-based free-floating BCG of 10 subjects was measured in microgravity. The signal-to-noise ratio (SNR) of the scale-based BCG was, on average, a factor of 2.1 (6.3 dB) higher than the free-floating method, suggesting that the tethered scale approach might be more robust in terms of signal quality. Additionally, this approach enables practical BCG-based hemodynamic monitoring in fractional-g environments, and on small space vehicles such as NASA's upcoming Orion capsule. The scale-based results in microgravity were also compared to ground measurements (1g), where there was an average 38.7 ms RJ interval reduction from ground to microgravity environments that is consistent across 9 of 10 subjects. This phenomenon is likely due to the transient increase in venous return, and consequent decrease in pre-ejection period, experienced during the microgravity time intervals.